Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...

The growth protein, MYC, was consistently found with RBM42, which spurs MYC production, in human pancreatic tumors. Above, microscopy for MYC (red) and RBM42 (green) in a representative pancreatic ...

Please provide your email address to receive an email when new articles are posted on . Inhibiting RMB42 disrupted production of Myc proteins in pancreatic cancer cells. This approach could curtail ...

Researchers at CSH Laboratory identified an oncogenic SRSF1–AURKA–MYC circuit driving pancreatic ductal adenocarcinoma.

Cambridge, MA, May 28 — Insilico Medicine (“Insilico”), in collaboration with research partner at Huadong Medicine Company, today announced the discovery of novel small-molecule inhibitors that ...

Professor Heide Ford, the University of Colorado Medicine Endowed Chair in Pharmacology, gave a presentation Wednesday on her lab’s research into the role of proteins in cancer growth and spread at ...